Silence Therapeutics plc Finite-Lived Intangible Asset, Expected Amortization, Year One
Silence Therapeutics plc (SLNCF) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $46.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-03-05
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $46.00K.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $45.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $46.00K 10-K · filed 2026-03-05 |
| 2024-12-31 | $45.00K 10-K · filed 2025-02-27 |